Hyman, Phelps & McNamara, P.C. Takes Top Honors in Two Prestigious Categories in 2023 LMG Life Sciences Awards

November 7, 2023

WASHINGTON, DC — Hyman, Phelps & McNamara, P.C. is pleased to announce it took top honors in two categories in the 2023 LMG Life Sciences Awards, which recognize the best life science practitioners and firms over the past 12 months from the United States, Canada, and Europe.

Hyman Phelps & McNamara received the following honors:

  • Tier 1 FDA: Pharmaceutical
  • Tier 1 FDA: Medical Device

Additionally, eight professionals are included in LMG’s coverage:  Robert A. Dormer (Hall of Fame), Jeffrey N. Gibbs (Hall of Fame), John A. GilbertGail H. JavittKurt R. KarstAlan M. KirschenbaumFrank J. Sasinowski, and Josephine M. Torrente.

“While our attorneys don’t do this work for the recognition, it is gratifying to see their excellent work recognized.  The LMG awards are reflective of HPM’s excellence across several of our core life sciences practices, from controlled substances work to drug development, to Hatch-Waxman, to drug pricing, to medical device regulation. That combined depth and breadth of experience is why clients come to us.  The excellent work of these and other professionals at HPM is why we’ve maintained a high level of client service for 43 years,” said JP Ellison, HPM’s managing director.

The LMG Life Sciences awards are based on case evidence and feedback from clients and peers and selected by the editors to provide attorneys and law firms with information on the legal market and the U.S. life sciences industry. Research for the guide was based on 1,000s of interviews and surveys completed by law firm partners active in the market.


Jeff Grizzel, Chief Marketing Officer
700 13th Street, N.W., Suite 1200
Washington, DC 20005
(202) 999-0302 cell
(202) 800-6116 direct